Biomark Diagnostics Inc. (CSE:BUX)
Canada · Delayed Price · Currency is CAD 0.3700
0.00 (0.00%)
Aug 12, 2025, 12:44 PM EDT
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 33.60 million as of August 12, 2025. Its market cap has increased by 85.75% in one year.
Market Cap
33.60M
Enterprise Value
32.20M
Revenue
154.22K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 40.39M to 33.60M, a decrease of -16.80%. That is a compound annual growth rate of -1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 33.60M | 127.18% |
| Dec 30, 2024 | 14.79M | -17.24% |
| Dec 29, 2023 | 17.87M | 24.67% |
| Dec 30, 2022 | 14.34M | -23.96% |
| Dec 30, 2021 | 18.85M | 116.77% |
| Dec 30, 2020 | 8.70M | -51.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.28B |
| Curaleaf Holdings | 2.14B |
| Sienna Senior Living | 1.72B |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.51B |
| WELL Health Technologies | 1.24B |
| Cronos Group | 1.22B |
| Extendicare | 1.10B |